The Pharmacy Times® Immuno-oncology Resource Center is a comprehensive resource for clinical news and expert insights on treatments that harness the body's immune system to fight cancer.
May 7th 2024
In Iraq, asymmetrical warfare tactics relied heavily on unconventional weaponry, requiring military physicians to improvise new medical techniques in order to increase rates of survival.
Continuing the Conversation: A Review of Targeted Therapies for Early-Stage Breast Cancer
0.5 Credit / Oncology, Women’s Health
View More
The Impact of Antibody-Drug Conjugates in Bladder Cancer and Gynecologic Malignancies
1.0 Credit / Oncology
View More
Opportunities to Optimize Treatment of Non-Small Cell Lung Cancer and Gastric Cancers With Antibody-Drug Conju...
1.0 Credit / Oncology
View More
Assessing the Role of Antibody-Drug Conjugates in Breast Cancer Treatment Pathways
1.0 Credit / Oncology
View More
Exploring the Value of Pharmacist-Led Toxicity Management for New and Emerging Antibody-Drug Conjugates Across...
1.25 Credits / Oncology
View More
Improving Patient Outcomes in TNBC: Immunotherapy, PARP, TROP2, Oh My!
2.0 Credits / Oncology
View More
A Pharmacologic Overview of Antibody-Drug Conjugates
2.0 Credits / Oncology
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Mu...
1.5 Credit / Hematology, Oncology
View More
Empowering Pharmacists to Improve Care for Patients with Myelofibrosis
1.0 Credit / Oncology
View More
Novel Therapeutic Approaches for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer: An Oncol...
1.0 Credit / Oncology, Pulmonology/Respiratory
View More
Updates and Insights in Managing Anti-Androgen Therapies in Prostate Cancer
1.5 Credits / Oncology, Urology
View More
Improving Safety and Efficacy of Frontline Treatment Regimens in Advanced Hepatocellular Carcinoma
1.0 Credit / Oncology
View More
Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncolog...
1.0 Credit / Hematology, Oncology
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Optimizing the Utilization of Targeted Therapies in CLL: Considerations and Insights for the Managed Care Prof...
1.5 Credit / Oncology
View More
Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals
1.0 Credit / Hematology, Oncology
View More
Improving the Delivery of CAR T-Cell Therapy for Multiple Myeloma
1.0 Credit / Oncology
View More
Preparing for the Use of Multi-Cancer Early Detection Tests: Opportunities for Managed Care Professionals to E...
1.5 Credits / Oncology
View More
The Challenges of Chemotherapy Drug Shortages: The Oncology Pharmacist’s Perspective and Opportunities for Mit...
1.0 Credit / Oncology
View More
Optimizing Safety and Utilization of Targeted Therapies in MET- or RET-Altered Non-Small Cell Lung Cancer
1.0 Credit / Oncology
View More
Non-Melanoma Skin Cancers: The Evolution of Treatment With Immune Checkpoint Inhibitors and Its Implications f...
1.0 Credit / Oncology, Dermatology
View More
Assessing Emerging Therapies and Multidisciplinary Practices in Managing Myelofibrosis
1.5 Credits / Hematology, Oncology
View More
Navigating the Complexities of Oncologic Immunotherapy and Vascular Endothelial Growth Factor Receptor Tyrosin...
1.5 Credit / Oncology
View More
Chronic Myeloid Leukemia: Navigating Drug Resistance and Optimizing Care
1.0 Credit / Hematologic Cancer, Hematology, Oncology
View More
Emerging Trends in the Use of FGFR Inhibitors for Advanced Cholangiocarcinoma Treatment
1.0 Credits / Oncology
View More
Maximizing Efficacy and Minimizing Toxicity of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer
1.0 Credits / Oncology
View More
PARP Inhibitors for Ovarian Cancer: An Oncology Pharmacist's Guide to the Latest Clinical Advancements
1.0 Credits / Oncology
View More
Balancing Anticancer Efficacy and Cardiovascular Safety: A Pharmacist's Guide
1.0 Credits / Oncology
View More
Balancing the Benefits and Risks of Asparaginase Treatment in Adults and Young Adults With Acute Lymphoblastic...
1.0 Credits / Oncology
View More
Lisocabtagene Maraleucel Delivers Deep, Durable Efficacy in Chronic Lymphocytic Leukemia
May 30th 2023Study shows 18.4% of patients with relapsed or refractory chronic lymphocytic leukemia treated with lisocabtagene maraleucel achieved a complete response (CR), with median duration of CR not reached at median follow-up of 21.1 months.
Read More
FDA Accepts Supplemental New Drug Application for Encorafenib, Binimetinib Combination in NSCLC
April 6th 2023The application is based on the PHAROS trial, which met its primary endpoint of objective response rate in patients with metastatic non–small cell lung cancer with a BRAF V600E mutation.
Read More
Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers
March 23rd 2023Drugs such as pembrolizumab, sacituzumab govitecan, and datopotamab deruxtecan all have growing bodies of evidence illustrating which patients with cancer are most likely to benefit and in which settings.
Read More